All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. AI wasn't the entire focus ...

MUNICH, Germany, Jan 11 (Reuters) - Bayern Munich, helped by two record-breaking VfL Wolfsburg own goals and two from man-of-the-match Michael Olise, demolished the visitors 8-1 in the Bundesliga on ...

Woot! The Rookie is back, and we could not be more excited about it. We know the drill. Some of you just prefer a scene-by-scene recap of the shenanigans, and we have you covered with our recap below.

Adrian Esterman receives funding from the NHMRC, MRFF and ARC. COVID rarely rates a mention in the news these days, yet it hasn’t gone away. SARS-CoV-2, the virus that causes COVID, is still with us.

TCS plans to retrain 1 lakh employees yearly as AI changes transform client demand and outsourcing models, said CTO Harrick Vin. (Reuters / Dado Ruvic / File Illustration) IT giant Tata Consultancy ...

Talk about a tension-filled hour! FBI Season 8 Episode 1 pit the New York Field Office against a small town so desperate to lower crime rates that the mayor was helping a private militia wreak havoc.

Chevrolet's Vortec series of engines is hugely popular. Designed with trucks in mind, Vortec engines prioritize low-end torque and durability over high compression ratios and high horsepower, unlike ...

Claudia Cardinale, the Italian movie star who appeared in such films as “The Pink Panther” and “Once Upon a Time in the West,” died Tuesday near Paris, according to her agent. The actress was 87.

Europe has endorsed an updated protein-based COVID-19 booster that targets the globally dominant LP.8.1 variant and extends eligibility to adolescents aged 12 years or older. The positive opinion came ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups Clinical findings reinforce preclinical data ...

Findings from this trial reinforce the preclinical data supporting the approval of the LP.8.1-adapted COVID-19 vaccine for the 2025-2026 season. Topline results were announced from a phase 3 trial ...